Claims
- 1. A compound of Formula I: wherein R3 is selected from the group consisting of alkyl and alkyloxy of from 1 to 8 carbon atoms; and pharmaceutically acceptable salts thereof.
- 2. The compound according to claim 1 wherein R3 is alkyloxy.
- 3. The compound according to claim 1 wherein said compound is selected from the group consisting of:2-[4-(4-isoproproxybenzyl)phenyl]amino-imidazoline; 2-{4-[4-sec-butoxy)benzyl]phenyl}amino-imidazoline; 2-[4-(4-ethoxybenzyl)phenyl]amino-imidazoline; 2-[4-(4-propoxybenyzl)phenyl]amino-imidazoline; 2-[4-(4-butoxybenzyl)phenyl]amino-imidazoline; 2-[4-(4-isobutoxybenzyl)phenyl]amino-imidazoline; 2-[4-(4-pentyloxybenzyl)phenyl]amino-imidazoline; and 2-{4-[4-(1-methylbutoxy)benzyl]phenyl}amino-imidazoline; and pharmaceutically acceptable salts thereof.
- 4. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of a compound of Formula I: wherein R3 is selected from the group consisting of alkyl and alkyloxy of from 1 to 8 carbon atoms; and pharmaceutically acceptable salts thereof.
- 5. The composition according to claim 4, wherein R3 is alkyloxy.
- 6. The composition according to claim 4, wherein said composition is selected from the group consisting of:2-[4-(4-isoproproxybenzyl)phenyl] amino-imidazoline; 2-{4-[4-sec-butoxy)benzyl]phenyl}amino-imidazoline; 2-[4-(4-ethoxybenzyl)phenyl]amino-imidazoline; 2-[4-(4-propoxybenyzl)phenyl]amino-imidazoline; 2-[4-(4-butoxybenzyl)phenyl]aamino-imidazoline; 2-[4-(4-isobutoxybenzyl)phenyl]amino-imidazoline; 2-[4-(4-pentyloxybenzyl)phenyl]amino-imidazoline; and 2-{4-[4-(1-methylbutoxy)benzyl]phenyl}amino-imidazoline; and pharmaceutically acceptable salts thereof.
CROSS-REFERENCE TO RELATED APPLICATIONS
This patent application claims priority under 35 U.S.C. 119(e) to co-pending U.S. Provisional Application Nos. 60/089,916, filed Jun. 19, 1998; 60/088,015, filed Jun. 4, 1998; and 60/057,808, filed Sep. 4, 1997.
US Referenced Citations (7)
Foreign Referenced Citations (4)
Number |
Date |
Country |
0 017 484 B1 |
Apr 1983 |
EP |
0 187 989 A1 |
Jul 1986 |
EP |
2 038 305 |
Jul 1980 |
GB |
WO 9630350 |
Oct 1996 |
WO |
Non-Patent Literature Citations (4)
Entry |
Murata et al., Nature 1997, 388, 678-682. |
Goodman & Gillman's, the Pharmacological Basis of Therapeutics, 9th edition, McGraw-Hill, New York, 1996, Chapter 26, 601-616. |
Byrn et al., Pharmaceutical Research 1995, 12(7), 945-954. |
K. Anderson, Pharmacological Reviews 1993, 45(3), 253-308. |
Provisional Applications (3)
|
Number |
Date |
Country |
|
60/089916 |
Jun 1998 |
US |
|
60/088015 |
Jun 1998 |
US |
|
60/057808 |
Sep 1997 |
US |